Clinical And Immunologic Responses To Human Immunodeficiency Virus (HIV) Type LSF2 gp120 Subunit Vaccine Combined With MF59 Adjuvant With Or Without Muramyl Tripeptide Dipalmitoyl Phosphatidylethanolamine In Non-HIV-Infected Human Volunteers-Reference-Cited by-同舟云学术

Clinical And Immunologic Responses To Human Immunodeficiency Virus (HIV) Type LSF2 gp120 Subunit Vaccine Combined With MF59 Adjuvant With Or Without Muramyl Tripeptide Dipalmitoyl Phosphatidylethanolamine In Non-HIV-Infected Human Volunteers

Published:1994-11-01 Issue:5 Volume:170 Page:1288-1291
ISSN:0022-1899
Container-title:Journal of Infectious Diseases
language:en
Short-container-title:Journal of Infectious Diseases

Author:

Kahn J. O.,Sinangil F.,Baenziger J.,Murcar N.,Wynne D.,Coleman R. L.,Steimer K. S.,Dekker C. L.,Chernoff D.

Publisher

Oxford University Press (OUP)

Subject

Infectious Diseases,Immunology and Allergy

Link

http://academic.oup.com/jid/article-pdf/170/5/1288/2742681/170-5-1288.pdf

Cited by 113 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Pulmonary vaccine delivery: An emerging strategy for vaccination and immunotherapy;Journal of Drug Delivery Science and Technology;2022-03

2. Amphiphilic desmuramyl peptides for the rational design of new vaccine adjuvants: Synthesis, in vitro modulation of inflammatory response and molecular docking studies;European Journal of Medicinal Chemistry;2021-01

3. T cell–derived soluble glycoprotein GPIbα mediates PGE 2 production in human monocytes activated with the vaccine adjuvant MDP;Science Signaling;2019-10-08

4. Generation and characterization of a bivalent protein boost for future clinical trials: HIV-1 subtypes CR01_AE and B gp120 antigens with a potent adjuvant;PLOS ONE;2018-04-26

5. Vaccine Adjuvant Nanotechnologies;Micro and Nanotechnology in Vaccine Development;2017